Specifically, plasma levels of MMP12 and ASM were significantly elevated in the COPD group compared to controls (p < 0.05), while NPNT and SNX1 levels were significantly reduced (p < 0.05). This evidence concerns the gene SNX1 and chronic obstructive pulmonary disease.